There have been no new cases of progressive multifocal leukoencephalopathy (PML) associated with Tysabri [natalizumab]

Source: Reactions Weekly, Volume 1, Number 1065, 2005-08-20 , pp. 2-2(1)

Publisher: Adis International

Keywords: Elan-Corporation; Multiple-sclerosis; Natalizumab, adverse reactions; Progressive-multifocal-leukoencephalopathy, drug-i; Research-and-development; Trial-result-clinical

Document Type: Short communication

Publication date: 2005-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers